Bin Jiang
30Patents
4h-index
51Co-inventors
66Inventor score
Filing activity: May 19, 1999 → Feb 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8846673B2 | Azaindazoles as kinase inhibitors and use thereof | Human Necessities | 18 | Active |
| US7294624B2 | Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases | Chemistry; Metallurgy | 8 | Expired |
| US7595317B2 | Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases | Chemistry; Metallurgy | 6 | Active |
| US10335392B2 | Cyclic compounds useful as modulators of TNF α | Chemistry; Metallurgy | 5 | Active |
| US9458171B2 | Pyrrolidinyl sulfone RORγ modulators | Chemistry; Metallurgy | 4 | Active |
| US7888381B2 | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof | Chemistry; Metallurgy | 4 | Active |
| US8034940B2 | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Chemistry; Metallurgy | 3 | Active |
| US6353112B1 | Sultams: Solid phase and other synthesis of anti-HIV compounds and compositions | Chemistry; Metallurgy | 3 | Expired |
| US9771320B2 | Carbocyclic sulfone RORγ modulators | Chemistry; Metallurgy | 1 | Active |
| US11266608B2 | Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method | Human Necessities | 1 | Active |
| US10463769B2 | Thromboresistant-anticoagulant extracellular matrix | Human Necessities | 1 | Active |
| US7569689B2 | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Chemistry; Metallurgy | 0 | Active |
| US7625921B2 | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8304539B2 | Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Human Necessities | 0 | Active |
| US7592461B2 | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12312357B2 | PRMT5 inhibiting compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8987268B2 | Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US9725443B2 | RORγ modulators | Chemistry; Metallurgy | 0 | Active |
| US9221826B2 | Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US10980882B2 | Biodegradable microsphere-hydrogel ocular drug delivery system | Chemistry; Metallurgy | 0 | Active |
| US10865191B2 | Heterocyclic compounds useful as modulators of TNF alpha | Chemistry; Metallurgy | 0 | Active |
| US8921368B2 | Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US9708253B2 | Cyclohexyl sulfone RORγ modulators | Chemistry; Metallurgy | 0 | Active |
| US10189840B2 | Substituted tricyclic heterocyclic compounds | Chemistry; Metallurgy | 0 | Active |
| US9663469B2 | RORγ modulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.